Based on the Maternus-Kliniken Aktiengesellschaft stock forecast from 0 analysts, the average analyst target price for Maternus-Kliniken Aktiengesellschaft is not available over the next 12 months. Maternus-Kliniken Aktiengesellschaft’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Maternus-Kliniken Aktiengesellschaft is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Maternus-Kliniken Aktiengesellschaft’s stock price was EUR 1.87. Maternus-Kliniken Aktiengesellschaft’s stock price has changed by -7.43% over the past week, -4.10% over the past month and +8.72% over the last year.
No recent analyst target price found for Maternus-Kliniken Aktiengesellschaft
No recent average analyst rating found for Maternus-Kliniken Aktiengesellschaft
Company Overview Maternus-Kliniken Aktiengesellschaft
Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. It also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and disability care services. The company was founded in 1877 and is headquartered in Berlin, Germany. Address: FranzOesische Strasse 53 - 55, Berlin, Germany, 10117 Read Less
Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. It also provides emergency call, assisted living, rehabilitation, and follow-...Read More
Frequently Asked Questions About Maternus-Kliniken Aktiengesellschaft (MAK:XETRA) Stock
Stock Target Advisor's fundamental analysis for Maternus-Kliniken Aktiengesellschaft's stock is Slightly Bearish.
Unfortunately we do not have enough data on MAK:XETRA's stock to indicate if its a good dividend stock.
Unfortunately we do not have enough data on MAK:XETRA's stock to indicate what its average analyst target is.
Unfortunately we do not have enough data on MAK:XETRA's stock to indicate if its overvalued.
The last closing price of MAK:XETRA's stock was EUR 1.87.
The most recent market capitalization for MAK:XETRA is EUR 0.04B.
Unfortunately we do not have enough analyst data on MAK:XETRA's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Maternus-Kliniken Aktiengesellschaft's stock.
As per our most recent records Maternus-Kliniken Aktiengesellschaft has 1,480 Employees.
Maternus-Kliniken Aktiengesellschaft's registered address is FranzOesische Strasse 53 - 55, Berlin, Germany, 10117.
You can get more information about it from Maternus-Kliniken Aktiengesellschaft's website at https://www.maternus.de.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Low market capitalization
This is among the smaller entities in its sectors with below median market capitalization. That may make it less stable in the long run unless it has a unique technology or market which can help it grow or get acquired in future.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for MAK:XETRA !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
Stocktwits
